Know Cancer

or
forgot password

    • cancer clinical trials in massachusetts

    • Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Lowell General Hospital
    NSMC Cancer Center - Peabody
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Tufts Medical Center
    Emerson Hospital
    Addison Gilbert Hospital
    Faulkner Hospital
    Lowell General Hospital
    Newton-Wellesley Hospital
    North Shore Medical Center Cancer Center
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Leukemia
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Lymphoma
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Cancer Center at Tufts - New England Medical Center
    Lahey Clinic Medical Center - Burlington
    Commonwealth Hematology-Oncology P.C. - Quincy
    UMASS Memorial Cancer Center - University Campus
    Kidney Cancer
    Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Lymphoma, Neuroblastoma, Sarcoma
    Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
    Cancer Research Center at Boston Medical Center
    Boston, Massachusetts 02118
    Multiple Myeloma and Plasma Cell Neoplasm
    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Floating Hospital for Children at Tufts - New England Medical Center

    Trial Locations
    Floating Hospital for Children at Tufts - New England Medical Center
    Massachusetts General Hospital
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    UMASS Memorial Cancer Center - University Campus
    Leukemia
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    DFCI/Brigham & Women's
    Boston, Massachusetts 02114
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    Tufts - New England Medical Center

    Trial Locations
    Tufts - New England Medical Center
    DFCI/Brigham & Women's
    Multiple Myeloma
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Morton Hospital & Medical Center
    Taunton, Massachusetts 02780
    Lymphoma
    Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130
    Healthy
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Lowell General Hospital
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Metastatic Cancer, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Boston Medical Center
    Brigham and Women's Hospital
    Caritas Saint Elizabeth's Medical Center
    Addison Gilbert Hospital
    Franklin Medical Center
    Holyoke Medical Center
    Lowell General Hospital
    Lawrence Memorial
    Holy Family Hospital
    Metrowest Medical Center Incorporated
    Norwood Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer